Drug General Information
Drug ID
D0N3FL
Former ID
DNC009713
Drug Name
PSB-0702
Drug Type
Small molecular drug
Indication Discovery agent Investigative [530157]
Structure
Download
2D MOL

3D MOL

Formula
C27H18N3NaO7S
Canonical SMILES
C1=CC=C(C=C1)NC2=C(C=C(C=C2)NC3=C4C(=C(C(=C3)C(=O)O)N)C<br />(=O)C5=CC=CC=C5C4=O)S(=O)(=O)[O-].[Na+]
InChI
1S/C27H19N3O7S.Na/c28-24-18(27(33)34)13-20(22-23(24)26(32)17-9-5-4-8-16(17)25(22)31)30-15-10-11-19(21(12-15)38(35,36)37)29-14-6-2-1-3-7-14;/h1-13,29-30H,28H2,(H,33,34)(H,35,36,37);/q;+1/p-1
InChIKey
PZRXTTYJQMKSRF-UHFFFAOYSA-M
PubChem Compound ID
Target and Pathway
Target(s) P2Y purinoceptor 12 Target Info Inhibitor [530157]
KEGG Pathway Platelet activation
Reactome P2Y receptors
G alpha (i) signalling events
WikiPathways GPCRs, Class A Rhodopsin-like
Signal amplification
GPCR ligand binding
GPCR downstream signaling
References
Ref 530157J Med Chem. 2009 Jun 25;52(12):3784-93.High-affinity, non-nucleotide-derived competitive antagonists of platelet P2Y12 receptors.
Ref 530157J Med Chem. 2009 Jun 25;52(12):3784-93.High-affinity, non-nucleotide-derived competitive antagonists of platelet P2Y12 receptors.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.